ProfileGDS5822 / ILMN_2430220
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 91% 93% 92% 90% 95% 90% 93% 91% 90% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1528.291
GSM1276600PDAC Late Ablation Control 2824.493
GSM1276601PDAC Late Ablation Control 3829.792
GSM1276602PDAC Late Ablation 146690
GSM1276603PDAC Late Ablation 21160.295
GSM1276604PDAC Late Ablation 352090
GSM1303940PDAC Late Ablation_anti-CTLA4 176093
GSM1303941PDAC Late Ablation_anti-CTLA4 2726.791
GSM1303942PDAC Late Ablation_anti-CTLA4 3559.790